Disopyramide
(dye-soe-PEER-uh-myde)
Definition | Special instructions | Missed dose | Side effects | Warning signs | Contact us
What is disopyramide?
Disopyramide (Norpace", Norpace CR") is a type of drug called an antiarrhythmic used to treat/or prevent abnormal rhythms or beasts of the heart. It is available as a capsule, controlled release capsule, or your pharmacist may be able to make a liquid.
Special Instructions
Do not discontinue this medication without talking to your child's doctor.
Because this medicine may interact with other medications, tell the doctor or pharmacist all other medications your child is taking, including prescriptions and over-the-counter (OTC).
Do not crush, break, or chew controlled release capsules. Controlled release capsules should be swallowed whole.
This medication should be given on an empty stomach (1 hour before or 2 hours after a meal).
Do not use after the expiration date on the bottle/package.
Keep this medication out of the reach of children.
If too much medication is taken by accident, call the Drug and Poison Information Center (DPIC), 513-636-5111 or 1-800-222-1222, or call our child's doctor immediately.
Back to top
If a Dose is Missed
For any medication information related to your child's dosing schedule and/or missed doses, contact the healthcare provider who prescribed the medication.
Side Effects
Call your child's doctor if the following effects continue or are bothersome:
Lightheadedness
Weakness
Diarrhea
Dry mouth
Constipation
Difficulty urinating
Blurred vision
Stomach pain or bloating
Headache
Back to top
Warning Signs
Call your child's doctor if your child develops any of the following symptoms:
Chest pain
Palpitations or heart racing
Swelling of the feet or hands
Skin rash or yellowing of the skin
Nausea/vomiting
Blurred vision
Unusual weight gain
Inability to urinate
Fainting or dizziness
Back to top
Contact us
For additional information on this or any Health Topic, please call the Family Resource Center, 513-636-7606, or your pediatrician.
Back to top
Patient Education Program V 5145 1/00
Rev. 9/05, 10/07
